Editorial team
ioQuanta Research Desk
-
Evidence date ·What does a later cancer diagnosis mean after antibody-guided radiation?
Review or Meta-AnalysisA 2021 review found later cancers in about 3% of radioimmunotherapy recipients; its separate treatment groups cannot show which approach is safer.
-
Evidence date ·The treatment clues researchers are seeking in kidney cancer scans
Review or Meta-AnalysisA 2021 review finds CT features may help predict response, progression, and survival across kidney cancer therapies; larger studies are needed before clinical use.
-
Evidence date ·The bond may decide whether a carbon-fiber steel repair holds
Review or Meta-AnalysisA 2021 review finds gains in some steel members repaired with carbon-fiber patches, while heat and moisture reveal limits of the adhesive bond.
-
Evidence date ·How the timing of cancer vaccine ingredients could help or hinder immunity
Review or Meta-AnalysisA 2021 review of cancer-vaccine delivery explains why rapid antigen clearance and very prolonged exposure could each undermine an immune response.
-
Evidence date ·Why doctors treated one man’s metastatic kidney cancer before surgery
Review or Meta-AnalysisTracked over timeAfter drug treatment, a kidney tumor shrank 27.4% but still met the criteria for stable disease. Surgery later found mostly dead tissue.
-
Evidence date ·What does an eight-study comparison say about kidney removal with immune-based treatment?
Review or Meta-AnalysisTracked over timeEight studies linked kidney removal plus immune treatment to better survival. Timing analyses addressed one bias, but the groups differed at the start.
-
Evidence date ·When kidney cancer spreads, does immunotherapy change the case for surgery?
Review or Meta-AnalysisTracked over timeA 2021 review found surgery more closely tied to survival in immunotherapy cohorts than in targeted-therapy cohorts. Patient selection may explain part of the gap.
-
Evidence date ·Enzymes can shape polymers, but what happens to the finished material?
Review or Meta-AnalysisEnzymes can prepare building blocks, form polymer chains and alter surfaces. A 2021 review explains why breakdown still depends on the material and its surroundings.
-
Evidence date ·Why treatment history changes what immune cells may mean in glioblastoma
Review or Meta-AnalysisTracked over timeA seven-study review linked higher CD8 immune-cell counts with worse survival in some treated glioblastoma patients, showing why sample timing matters.
-
Evidence date ·Dual immune blockade changed T cells and suppressive cells in mouse glioblastoma tumors
Clinical TrialTracked over timeIn mice with glioblastoma, paired checkpoint blockade extended survival, raised the share of CD8 T cells in tumors and reduced one suppressive-cell subtype.